In accordance, we found that PAP-1 treatment in glioma-bearing mice significantly decreased peritumoral staining with GFAP (Fig. 2h), confirming that the increased glutamate transporter activity induced by Kv1.3 inhibition correlates with the reduction of astrogliosis. The gene discussed is KCNA3; the disease is central nervous system cancer.